Inventor
JONG GYUN KIM
Inventor
KR
Overview
Patents· 16 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
H01Mprimary
H01MProcesses or means, e.g. batteries, for the direct conversion of chemical energy into electrical energy13%
Y02EReduction of greenhouse gas [ghg] emissions, related to energy generation, transmission or distribution13%
A61KPreparations for medical, dental or toiletry purposes10%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations10%
Y02TClimate change mitigation technologies related to transportation8%
B60LPropulsion of electrically-propelled vehicles6%
C07KPeptides6%
C07BGeneral methods of organic chemistry5%
C07CAcyclic or carbocyclic compounds5%
C07DHeterocyclic compounds5%
PatentTitleYear
12,428,401Salt of an aminopyridine derivative compound, a crystalline form thereof, and a process for preparing the same202512,368,172Hydrogen supply system for fuel cell and inspection method thereof202512,347,900Cold start control method and system for fuel cell vehicles202512,327,897Operation controller of fuel cell and operation control method thereof202512,288,906System and method for determining performance of fuel cell stack202512,051,834Device for diagnosing valve failure of fuel cell system202411,981,659Salt of an aminopyridine derivative compound, a crystalline form thereof, and a process for preparing the same202411,757,113Method and system for correcting offset of hydrogen pressure sensor202311,588,159Control system and method for preventing overheating of a fuel cell202311,560,416Method for producing dual function proteins and its derivatives202311,524,571Liquid level detecting apparatus of tank for vehicle202211,515,549Method of recovering performance of fuel cell stack202211,453,656Salt of an aminopyridine derivative compound, a crystalline form thereof, and a process for preparing the same202211,179,440Pharmaceutical composition containing FGF21 mutant fusion protein and method for treating hepatitis, hepatic fibrosis, and hepatic cirrhosis202111,142,557Long-acting FGF21 fusion proteins and pharmaceutical composition comprising same202111,136,364Dual function proteins comprising FGF21 mutant protein and pharmaceutical composition comprising same2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2025Patents assigned to YUHAN CORP (7)· patent assignee history
2021–2025Based in KR· patent location history
2022–2025Patents assigned to HYUNDAI MOTOR CO LTD (9)· patent assignee history
2022Patents assigned to KIA MOTORS CORP (2)· patent assignee history
2023–2025Patents assigned to KIA CORP (7)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| HYUNDAI MOTOR CO LTD | 9 | 2022–2025 |
| KIA CORP | 7 | 2023–2025 |
| YUHAN CORP | 7 | 2021–2025 |
| KIA MOTORS CORP | 2 | 2022 |
Locations
| Location | Patents | Span |
|---|---|---|
| KR | 16 | 2021–2025 |